BioAtla, Inc. (BCAB) Tops Q1 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.48), $0.06 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• B.Riley on Nayax (NYAX): 'Sell-Off Overshoots the Story'
• Turning Point Brands (TPB) PT Lowered to $90 at Oppenheimer